🇺🇸 FDA
Patent

US 7439231

Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof

granted A61KA61K38/00A61P

Quick answer

US patent 7439231 (Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof) held by Provid Pharmaceuticals Inc. expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provid Pharmaceuticals Inc.
Grant date
Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61P, A61P19/02, A61P25/00